These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36768551)

  • 1. The Utility of Amino Acid Metabolites in the Diagnosis of Major Depressive Disorder and Correlations with Depression Severity.
    Ho CSH; Tay GWN; Wee HN; Ching J
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of the Cortical Haemodynamic Response Measured by Functional Near-Infrared Spectroscopy and Amino Acid Analysis to Aid in the Diagnosis of Major Depressive Disorder.
    Ong SK; Husain SF; Wee HN; Ching J; Kovalik JP; Cheng MS; Schwarz H; Tang TB; Ho CS
    Diagnostics (Basel); 2021 Oct; 11(11):. PubMed ID: 34829325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using an Interpretable Amino Acid-Based Machine Learning Method to Enhance the Diagnosis of Major Depressive Disorder.
    Ho CSH; Tan TWK; Khoe HCH; Chan YL; Tay GWN; Tang TB
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592058
    [No Abstract]   [Full Text] [Related]  

  • 4. Decreased plasma neuroactive amino acids and increased nitric oxide levels in melancholic major depressive disorder.
    Lu YR; Fu XY; Shi LG; Jiang Y; Wu JL; Weng XJ; Wang ZP; Wu XY; Lin Z; Liu WB; Li HC; Luo JH; Bao AM
    BMC Psychiatry; 2014 Apr; 14():123. PubMed ID: 24767108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-targeted Metabolomics Profiling of Plasma Samples From Patients With Major Depressive Disorder.
    Wu Z; Yu H; Tian Y; Wang Y; He Y; Lan T; Li Y; Bai M; Chen X; Chen Z; Ji P; Zhang H; Jin X; Song J; Cheng K; Xie P
    Front Psychiatry; 2021; 12():810302. PubMed ID: 35264984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of serum amino acids and non-enzymatic antioxidants in drug-naïve first-episode major depressive disorder.
    Islam MR; Ali S; Karmoker JR; Kadir MF; Ahmed MU; Nahar Z; Islam SMA; Islam MS; Hasnat A; Islam MS
    BMC Psychiatry; 2020 Jun; 20(1):333. PubMed ID: 32580709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma amino acid profile in major depressive disorder: Analyses in two independent case-control sample sets.
    Ogawa S; Koga N; Hattori K; Matsuo J; Ota M; Hori H; Sasayama D; Teraishi T; Ishida I; Yoshida F; Yoshida S; Noda T; Higuchi T; Kunugi H
    J Psychiatr Res; 2018 Jan; 96():23-32. PubMed ID: 28950111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma amino acid profiling in major depressive disorder treated with selective serotonin reuptake inhibitors.
    Woo HI; Chun MR; Yang JS; Lim SW; Kim MJ; Kim SW; Myung WJ; Kim DK; Lee SY
    CNS Neurosci Ther; 2015 May; 21(5):417-24. PubMed ID: 25611566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.
    Hashimoto K; Bruno D; Nierenberg J; Marmar CR; Zetterberg H; Blennow K; Pomara N
    Transl Psychiatry; 2016 Mar; 6(3):e744. PubMed ID: 26926880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum interleukin-12 and interleukin-4 as potential biomarkers for the diagnosis of major depressive disorder.
    Sarmin N; Roknuzzaman ASM; Mouree TZ; Islam MR; Al Mahmud Z
    Sci Rep; 2024 Jan; 14(1):1652. PubMed ID: 38238514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes.
    Doolin K; Allers KA; Pleiner S; Liesener A; Farrell C; Tozzi L; O'Hanlon E; Roddy D; Frodl T; Harkin A; O'Keane V
    Psychoneuroendocrinology; 2018 Sep; 95():8-17. PubMed ID: 29787958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
    Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
    J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel urinary metabolite signature for diagnosing major depressive disorder.
    Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
    J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota-Derived Inflammation-Related Serum Metabolites as Potential Biomarkers for Major Depressive Disorder.
    Bai S; Xie J; Bai H; Tian T; Zou T; Chen JJ
    J Inflamm Res; 2021; 14():3755-3766. PubMed ID: 34393496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alterations of plasma aspartic acid, glycine and asparagine levels in patients with major depressive disorder].
    Fu XY; Lu YR; Wu JL; Wu XY; Bao AM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 41(2):132-8. PubMed ID: 22499508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma Metabolomics Profiling of Metabolic Pathways Affected by Major Depressive Disorder.
    Du Y; Wei J; Zhang Z; Yang X; Wang M; Wang Y; Qi X; Zhao L; Tian Y; Guo W; Wang Q; Deng W; Li M; Lin D; Li T; Ma X
    Front Psychiatry; 2021; 12():644555. PubMed ID: 34646171
    [No Abstract]   [Full Text] [Related]  

  • 17. Relationship between neurotoxic kynurenine metabolites and reductions in right medial prefrontal cortical thickness in major depressive disorder.
    Meier TB; Drevets WC; Wurfel BE; Ford BN; Morris HM; Victor TA; Bodurka J; Teague TK; Dantzer R; Savitz J
    Brain Behav Immun; 2016 Mar; 53():39-48. PubMed ID: 26546831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monocyte chemoattractant protein-1 levels are associated with major depressive disorder.
    Proma MA; Daria S; Nahar Z; Ashraful Islam SM; Bhuiyan MA; Islam MR
    J Basic Clin Physiol Pharmacol; 2022 Nov; 33(6):735-741. PubMed ID: 34983131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma metabolites were associated with spatial working memory in major depressive disorder.
    Du Y; Wei J; Yang X; Dou Y; Zhao L; Qi X; Yu X; Guo W; Wang Q; Deng W; Li M; Lin D; Li T; Ma X
    Medicine (Baltimore); 2021 Feb; 100(8):e24581. PubMed ID: 33663067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Serum Lysophosphatidic Acid and Lysophosphatidylcholine Levels in Major Depressive Disorder Patients.
    Riya S; Sultana S; Daria S; Proma MA; Bhuiyan MA; Haque MA; Islam MR
    Cureus; 2020 Dec; 12(12):e12388. PubMed ID: 33542861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.